Has Rachel Cullina received payments from drug or device companies?

Yes. Drug and device makers reported $4,233 in general payments to Rachel Cullina across 232 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rachel Cullina did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rachel Cullina come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rachel Cullina

Family · Indianapolis, INNPI 1952914764

Payments from drug & device makers

$4,233in general payments, 2019–2025

Across 232 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$667
Novo Nordisk$550
Lilly USA, LLC$410
Amgen$350
Bayer$328
Johnson & Johnson$246
plus $2K from 33 others

What the payments were for

Food & beverage$4,13498%
Education$992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	42	$667
Novo Nordisk	31	$550
Lilly USA, LLC	26	$410
Amgen	17	$350
Bayer	14	$328
Johnson & Johnson(2 entities)	10	$246
AstraZeneca(2 entities)	11	$193
Novartis	7	$184
Pfizer	9	$159
Exact Sciences	4	$79
UCB, Inc.	4	$78
Sanofi-aventis U.S. LLC	4	$65
Sun Pharmaceutical Industries Inc.	3	$63
GSK	4	$63
Incyte Corporation	3	$62
Supernus Pharmaceuticals, Inc.	3	$60
Boehringer Ingelheim	3	$59
Idorsia Pharmaceuticals US Inc	3	$56
Biohaven Pharmaceutical Holding Company Ltd.	3	$44
Organon	2	$42
Takeda Pharmaceuticals U.S.A., Inc.	3	$40
Otsuka America Pharmaceutical, Inc.	2	$40
Sanofi Pasteur Inc.	2	$37
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$35
Regeneron Healthcare Solutions, Inc.	2	$33
Astellas Pharma US Inc	2	$30
Ironshore Pharmaceuticals Inc.	2	$27
Antares Pharma, Inc.	2	$26
Merck	2	$24
Amneal Pharmaceuticals LLC	1	$23
LEO Pharma Inc.	1	$22
Sanofi	1	$21
Paratek Pharmaceuticals, Inc.	1	$21
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$19
Kowa Pharmaceuticals America, Inc.	1	$19
Galderma Laboratories, L.p.	1	$16
Abbott	1	$14
Teva Pharmaceuticals USA, Inc.	1	$13
Collegium Pharmaceutical, Inc.	1	$12

How this compares

$4,233 in reported general payments places this provider in the 90th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Betamethasone Dipropionate	42	$1,257
Metronidazole	15	$690
Ketoconazole	61	$648
Doxycycline Hyclate	32	$435
Triamcinolone Acetonide	56	$335
MethotrexateMethotrexate Sodium	16	$241
Terbinafine Hcl	20	$225
Fluconazole	11	$103
Cephalexin	24	$82
Hydrocortisone	21	$70
Silver Sulfadiazine	12	$46
Prednisone	15	$43

Paid to pharmacies, not to this prescriber.

Other family in Indianapolis

Tina SizemoreIndianapolis$888K
Marla MosesIndianapolis$142K
Leslye FisherIndianapolis$73K
Alicia WettrickIndianapolis$72K
Christine BaltIndianapolis$30K
Kathryn KennedyIndianapolis$29K
Andrea RandallIndianapolis$27K
Deidre ArmsIndianapolis$26K
Carrie GravesIndianapolis$16K
Dominique LevequeIndianapolis$16K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →